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Introduction  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Objectives 
As part of a project exploring whether prescription factors could be 
used to identify patients at risk of readmission, the purpose of this 
study was to determine whether prescription of new medicines on 
discharge, particularly prescriptions meeting the NMS criteria, were 
associated with an increased risk of readmission. 
 
Method 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referrals to the NMS were not routinely made by the Trust. Capacity to 
consent for and willingness to participate in the NMS was not assessed. 
 
 
 
 
 
 
Results  
TTOs were completed for 1407 patients discharged home from the 
Trust s͛ SSUs during the study period. Two hundred thirty-three patients 
were readmitted and 42 patients died within 30 days. A small but 
statistically significant association with readmission was identified for 
patients prescribed at least one new medicine compared with patients 
not prescribed any new medicine, however no significant difference 
was identified when comparing patients whose prescriptions met the 
NMS criteria with those who were not eligible for the NMS. Table 1 
details the results with according to prescription characteristics: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion/conclusion  
The association of newly prescribed medicines with readmission 
demonstrates that pharmacists are ideally placed to identify patients at 
increased risk of readmission at the point of discharge, if not before. 
However, the finding that patients whose discharge prescriptions met 
the NMS criteria were not at increased risk of readmission indicates 
that they are not necessarily the patients secondary care need to 
prioritise in order to reduce readmissions.  
 
It is acknowledged that the group identified as at increased risk of 
readmission accounted for the majority of patients, and as such further 
work is being undertaken to identify risk factors for patients not 
prescribed a new medicine, as well as to further refine the association 
for those who were. Data are being analysed according to therapeutic 
class with a view to identifying ͚high-risk͛ medicines specific to 
readmission, which it is hoped will be useful to clinical pharmacists for 
identifying patients at increased risk of readmission in their routine 
practice. 
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Around five per cent of 
hospital admissions are due 
to preventable adverse drug 
reactions [1] 
There is little evidence of 
which medicines are 
associated with 
readmission 
Prescription of 
cardiovascular medication 
at discharge has previously 
been identified as 
associated with 
readmission [2] 
Over half of New Medicine 
Service (NMS) 
consultations involve 
antihypertensives, 
antiplatelets and 
anticoagulants [3} 
Are patients who are 
eligible to receive the NMS 
at increased risk of 
readmission?  
This may provide valuable 
motivation for hospital 
teams to make the referrals 
necessary for patients to 
receive the service 
Pearson’s Chi 
square and phi 
coefficient 
using IBM 
SPSS Statistics 
22 
Data were 
collected 
retrospectively 
from discharge 
notes (TTOs) 
Included all 
adults discharged 
home from the 
medical short 
stay units (SSUs) 
over 6 months 
Patients were 
categorised 
according to 
whether they 
were readmitted 
or not 
Prescriptions 
were categorised 
according to 
whether they met 
the NMS criteria 
or not {3,4] 
Table 1: New medicines, NMS eligibility, and readmissions 
NMS medicine New medicine All 
Discharged & 
surviving 30 
days 
13%, 172 /1365 
 
76%, 1040/1365  
 
1365 
Readmitted 
(compared to) 
ȶ 
p 
ȷ2 
17%, 29/172  
(17%, 204/1193) 
N/A 
>0.05  
0.006 
19%, 193/1040  
(12%, 40/325) 
0.071 
0.009  
6.833  
17%, 233/1365 
